XBIOTECH INC. Foreign Currency Transaction Gain (Loss), before Tax
XBIOTECH INC. (XBIT) reported Foreign Currency Transaction Gain (Loss), before Tax of -$1.41 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-08-13
- XBIOTECH INC. foreign currency transaction gain (loss), before tax for the quarter ending 2026-06-30 was -$1.41M, a 145.83% decline year-over-year.
- XBIOTECH INC. foreign currency transaction gain (loss), before tax for the quarter ending 2026-03-31 was -$1.13M, a 498.59% decline year-over-year.
- XBIOTECH INC. foreign currency transaction gain (loss), before tax for the quarter ending 2025-12-31 was $1.17M.
- XBIOTECH INC. foreign currency transaction gain (loss), before tax for the quarter ending 2025-09-30 was -$1.20M, a 269.87% decline year-over-year.
- XBIOTECH INC. foreign currency transaction gain (loss), before tax for fiscal 2025 was $3.33M.
- XBIOTECH INC. foreign currency transaction gain (loss), before tax for fiscal 2024 was -$5.53M, a 392.08% decline from fiscal 2023.
- XBIOTECH INC. foreign currency transaction gain (loss), before tax for fiscal 2023 was $1.89M.
- XBIOTECH INC. foreign currency transaction gain (loss), before tax for fiscal 2022 was -$2.80M.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.41M 10-Q · filed 2026-08-13 | -$2.54M 10-Q · filed 2026-08-13 | -$1.37M derived: sum of 3 quarters · filed 2026-08-13 | -$2.58M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$1.13M 10-Q · filed 2026-05-14 | $38.00K derived: sum of 2 quarters · filed 2026-05-14 | -$1.16M derived: sum of 3 quarters · filed 2026-05-14 | $1.92M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$31.00K derived: sum of 2 quarters · filed 2026-03-13 | $3.05M derived: sum of 3 quarters · filed 2026-08-13 | $3.33M 10-K · filed 2026-03-13 |
| 2025-09-30 | -$1.20M 10-Q · filed 2025-11-12 | $1.88M derived: sum of 2 quarters · filed 2026-08-13 | $2.16M 10-Q · filed 2025-11-12 | -$1.94M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $3.08M 10-Q · filed 2026-08-13 | $3.37M 10-Q · filed 2026-08-13 | -$735.00K derived: sum of 3 quarters · filed 2026-08-13 | -$28.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $284.00K 10-Q · filed 2026-05-14 | -$3.82M derived: sum of 2 quarters · filed 2026-05-14 | -$3.11M derived: sum of 3 quarters · filed 2026-05-14 | -$3.66M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | -$4.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$3.39M derived: sum of 2 quarters · filed 2026-03-13 | -$3.95M derived: sum of 3 quarters · filed 2026-03-13 | -$5.53M 10-K · filed 2026-03-13 |
| 2024-09-30 | $707.00K 10-Q · filed 2025-11-12 | $153.00K derived: sum of 2 quarters · filed 2025-11-12 | -$1.43M 10-Q · filed 2025-11-12 | -$182.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$554.00K 10-Q · filed 2025-08-13 | -$2.14M 10-Q · filed 2025-08-13 | -$889.00K derived: sum of 3 quarters · filed 2025-08-13 | -$1.95M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | -$1.58M 10-Q · filed 2025-05-14 | -$335.00K derived: sum of 2 quarters · filed 2025-05-14 | -$1.40M derived: sum of 3 quarters · filed 2025-05-14 | -$72.00K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $182.00K derived: sum of 2 quarters · filed 2025-03-18 | $1.51M derived: sum of 3 quarters · filed 2025-03-18 | $1.89M 10-K · filed 2025-03-18 |
| 2023-09-30 | -$1.06M 10-Q · filed 2024-11-13 | $263.00K derived: sum of 2 quarters · filed 2024-11-13 | $646.00K 10-Q · filed 2024-11-13 | $3.71M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $1.33M 10-Q · filed 2024-08-12 | $1.71M 10-Q · filed 2024-08-12 | $4.78M derived: sum of 3 quarters · filed 2024-08-12 | -$99.00K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $383.00K 10-Q · filed 2024-05-10 | $3.45M derived: sum of 2 quarters · filed 2024-05-10 | -$1.43M derived: sum of 3 quarters · filed 2024-05-10 | -$3.71M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $3.07M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | -$1.81M derived: sum of 2 quarters · filed 2024-03-15 | -$4.09M derived: sum of 3 quarters · filed 2024-03-15 | -$2.80M 10-K · filed 2024-03-15 |
| 2022-09-30 | -$4.88M 10-Q · filed 2023-11-09 | -$7.16M derived: sum of 2 quarters · filed 2023-11-09 | -$5.87M 10-Q · filed 2023-11-09 | -$6.45M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$2.28M 10-Q · filed 2023-08-11 | -$990.00K 10-Q · filed 2023-08-11 | -$1.57M derived: sum of 3 quarters · filed 2023-08-11 | -$2.90M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $1.29M 10-Q · filed 2023-05-10 | $706.00K derived: sum of 2 quarters · filed 2023-05-10 | -$622.00K derived: sum of 3 quarters · filed 2023-05-10 | $171.00K derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | -$584.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | -$1.91M derived: sum of 2 quarters · filed 2023-03-15 | -$1.12M derived: sum of 3 quarters · filed 2023-03-15 | -$711.00K 10-K · filed 2023-03-15 |
| 2021-09-30 | -$1.33M 10-Q · filed 2022-11-09 | -$535.00K derived: sum of 2 quarters · filed 2022-11-09 | -$127.00K 10-Q · filed 2022-11-09 | $2.58M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $793.00K 10-Q · filed 2022-08-10 | $1.20M 10-Q · filed 2022-08-10 | $3.90M derived: sum of 3 quarters · filed 2022-08-10 | $5.26M derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $409.00K 10-Q · filed 2022-05-10 | $3.11M derived: sum of 2 quarters · filed 2022-05-10 | $4.46M derived: sum of 3 quarters · filed 2022-05-10 | $4.00M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $2.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $4.05M derived: sum of 2 quarters · filed 2022-03-15 | $3.59M derived: sum of 3 quarters · filed 2022-03-15 | $3.50M 10-K · filed 2022-03-15 |
| 2020-09-30 | $1.35M 10-Q · filed 2021-11-09 | $887.00K derived: sum of 2 quarters · filed 2021-11-09 | $794.00K 10-Q · filed 2021-11-09 | $239.00K derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-06-30 | -$465.00K 10-Q · filed 2021-08-09 | -$558.00K 10-Q · filed 2021-08-09 | -$1.11M derived: sum of 3 quarters · filed 2022-03-15 | -$1.40M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-03-31 | -$93.00K 10-Q · filed 2021-05-10 | -$648.00K derived: sum of 2 quarters · filed 2022-03-15 | -$937.00K derived: sum of 3 quarters · filed 2022-03-15 | -$835.00K derived: sum of 4 quarters · filed 2022-03-15 |
| 2019-12-31 | -$555.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | -$844.00K derived: sum of 2 quarters · filed 2022-03-15 | -$742.00K derived: sum of 3 quarters · filed 2022-03-15 | -$888.00K 10-K · filed 2022-03-15 |
| 2019-09-30 | -$289.00K 10-Q · filed 2020-11-09 | -$187.00K derived: sum of 2 quarters · filed 2020-11-09 | -$333.00K 10-Q · filed 2020-11-09 | -$470.00K derived: sum of 4 quarters · filed 2021-03-16 |
| 2019-06-30 | $102.00K 10-Q · filed 2020-08-10 | -$44.00K 10-Q · filed 2020-08-10 | -$181.00K derived: sum of 3 quarters · filed 2021-03-16 | -$217.00K derived: sum of 4 quarters · filed 2021-03-16 |
| 2019-03-31 | -$146.00K 10-Q · filed 2020-05-11 | -$283.00K derived: sum of 2 quarters · filed 2021-03-16 | -$319.00K derived: sum of 3 quarters · filed 2021-03-16 | -$712.00K derived: sum of 4 quarters · filed 2021-03-16 |
| 2018-12-31 | -$137.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | -$173.00K derived: sum of 2 quarters · filed 2021-03-16 | -$566.00K derived: sum of 3 quarters · filed 2021-03-16 | -$548.00K 10-K · filed 2021-03-16 |
| 2018-09-30 | -$36.00K 10-Q · filed 2019-11-12 | -$429.00K derived: sum of 2 quarters · filed 2019-11-12 | -$411.00K 10-Q · filed 2019-11-12 | -$222.00K derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-06-30 | -$393.00K 10-Q · filed 2019-08-09 | -$376.00K 10-Q · filed 2019-08-09 | -$186.00K derived: sum of 3 quarters · filed 2020-03-16 | $79.00K derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-03-31 | $17.00K 10-Q · filed 2019-05-09 | $207.00K derived: sum of 2 quarters · filed 2020-03-16 | $472.00K derived: sum of 3 quarters · filed 2020-03-16 | $913.00K derived: sum of 4 quarters · filed 2020-03-16 |
| 2017-12-31 | $190.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $455.00K derived: sum of 2 quarters · filed 2020-03-16 | $896.00K derived: sum of 3 quarters · filed 2020-03-16 | $555.00K 10-K · filed 2020-03-16 |
| 2017-09-30 | $265.00K 10-Q · filed 2018-10-31 | $706.00K derived: sum of 2 quarters · filed 2018-10-31 | $365.00K 10-Q · filed 2018-10-31 | $359.00K derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-06-30 | $441.00K 10-Q · filed 2018-08-09 | $99.00K 10-Q · filed 2018-08-09 | $94.00K derived: sum of 3 quarters · filed 2019-03-15 | $69.00K derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-03-31 | -$341.00K 10-Q · filed 2018-05-08 | -$347.00K derived: sum of 2 quarters · filed 2019-03-15 | -$372.00K derived: sum of 3 quarters · filed 2019-03-15 | -$379.00K derived: sum of 4 quarters · filed 2019-03-15 |
| 2016-12-31 | -$6.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-03-15 | -$31.00K derived: sum of 2 quarters · filed 2019-03-15 | -$38.00K derived: sum of 3 quarters · filed 2019-03-15 | -$47.00K 10-K/A · filed 2019-03-15 |
| 2016-09-30 | -$25.00K 10-Q · filed 2017-11-09 | -$32.00K derived: sum of 2 quarters · filed 2017-11-09 | -$41.00K 10-Q · filed 2017-11-09 | $120.00K derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-06-30 | -$7.00K 10-Q · filed 2017-08-08 | -$16.00K 10-Q · filed 2017-08-08 | $145.00K derived: sum of 3 quarters · filed 2018-03-16 | $223.00K derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-03-31 | -$9.00K 10-Q · filed 2017-05-10 | $152.00K derived: sum of 2 quarters · filed 2018-03-16 | $230.00K derived: sum of 3 quarters · filed 2018-03-16 | -$93.00K derived: sum of 4 quarters · filed 2018-03-16 |
| 2015-12-31 | $161.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $239.00K derived: sum of 2 quarters · filed 2018-03-16 | -$84.00K derived: sum of 3 quarters · filed 2018-03-16 | $6.00K 10-K · filed 2018-03-16 |
| 2015-09-30 | $78.00K 10-Q · filed 2016-11-14 | -$245.00K derived: sum of 2 quarters · filed 2016-11-14 | -$155.00K 10-Q · filed 2016-11-14 | -$118.00K derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-06-30 | -$323.00K 10-Q · filed 2016-08-12 | -$232.00K 10-Q · filed 2016-08-12 | -$196.00K derived: sum of 3 quarters · filed 2017-03-16 | -$179.00K derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-03-31 | $91.00K 10-Q · filed 2016-05-13 | $127.00K derived: sum of 2 quarters · filed 2017-03-16 | $144.00K derived: sum of 3 quarters · filed 2017-03-16 | $143.00K derived: sum of 4 quarters · filed 2017-03-16 |
| 2014-12-31 | $36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $53.00K derived: sum of 2 quarters · filed 2017-03-16 | $52.00K derived: sum of 3 quarters · filed 2017-03-16 | $53.00K 10-K · filed 2017-03-16 |
| 2014-09-30 | $17.00K 10-Q · filed 2015-11-13 | $16.00K derived: sum of 2 quarters · filed 2015-11-13 | $17.00K 10-Q · filed 2015-11-13 | |
| 2014-06-30 | -$1.00K 10-Q · filed 2015-08-14 | $0.00 derived: sum of 2 quarters · filed 2015-08-14 | ||
| 2014-03-31 | $1.00K 10-Q · filed 2015-06-18 | |||
| 2013-12-31 | -$3.00K 10-K · filed 2016-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |